Skip to main content
Top
Published in:

28-09-2024 | Cystic Fibrosis | Correspondence

IgG Concentrations Distinguish People with Cystic Fibrosis and Mycobacterium abscessus

Authors: Bryce Lang, Don Hayes Jr, Richard T. Robinson

Published in: Lung | Issue 6/2024

Login to get access

Excerpt

Respiratory infections with nontuberculous mycobacteria (NTM) are difficult to diagnose in people with cystic fibrosis (PwCF), as the CF lung is often colonized with numerous other bacteria and fungi that confound NTM detection [1]. In cases of suspected NTM infection in PwCF, an easily measured biomarker that correlates with the presence of NTM in the lung would benefit differential diagnosis. We recently reported [2] that high-frequency airway B cells distinguish PwCF and respiratory NTM infection (NTMPOS) from PwCF who are not infected with NTM (NTMNEG). Since immunoglobulin (Ig) is a B-cell product that is routinely and easily measured in most clinical diagnostic laboratories, we performed a secondary analysis of the bronchoalveolar lavage fluid (BALF) samples collected for our previous study [2] to determine if airway levels of two immunoglobulin isotypes (IgG, IgM) corresponded to their NTM status. The results of this analysis are shown in Fig. 1 and demonstrate that BALF from NTMPOS PwCF had significantly higher concentrations of IgG relative to NTMNEG PwCF (Fig. 1A, p < 0.0001). This pattern was also observed for IgM, albeit a less significant difference (Fig. 1B, p = 0.012). Only within our NTMPOS cohort were there several samples with IgG and IgM concentrations above the fit curve range of the assay (Meso Scale Diagnostics Isotyping Panel). The same data are expressed as individual and lobe-specific IgG and IgM values in Fig. 1C, D, respectively. As we reported, PwCF in our NTMNEG and NTMPOS groups had concomitant, polymicrobial infections comprising S. aureus, P. aeruginosa, Aspergillus, and Candida spp. and were otherwise demographically similar; the only difference between both groups was the presence of NTM. Notably, BALF samples derived from individuals infected with M. abscessus (blue data points in Fig. 1A, B, NTMNEG2-4 in Fig. 1C, D) were generally distinguished by higher IgG concentrations than those infected with M. intracellulare / M. chimaera (orange data points in Fig. 1A, B, NTMNEG1 in Fig. 1C, D). Based on these results, we recommend the further examination of IgG in BALF (or other respiratory samples collected during standard-of-care) as it distinguishes CF-NTMPOS individuals in their patient communities. If broadly observed across multiple institutions, then we believe BALF IgG—an easily measured analyte—may benefit the differential diagnosis of NTM infection in PwCF.
Literature
1.
go back to reference Kumar K, Ponnuswamy A, Capstick TG, Chen C, McCabe D, Hurst R, Morrison L, Moore F, Gallardo M, Keane J, Harwood S, Sinnett T, Bryant S, Breen R, Kon OM, Lipman M, Loebinger MR, Dhasmana DJ (2024) Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management. Clin Med (Lond) 24(1):100017. https://doi.org/10.1016/j.clinme.2024.100017CrossRefPubMed Kumar K, Ponnuswamy A, Capstick TG, Chen C, McCabe D, Hurst R, Morrison L, Moore F, Gallardo M, Keane J, Harwood S, Sinnett T, Bryant S, Breen R, Kon OM, Lipman M, Loebinger MR, Dhasmana DJ (2024) Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management. Clin Med (Lond) 24(1):100017. https://​doi.​org/​10.​1016/​j.​clinme.​2024.​100017CrossRefPubMed
Metadata
Title
IgG Concentrations Distinguish People with Cystic Fibrosis and Mycobacterium abscessus
Authors
Bryce Lang
Don Hayes Jr
Richard T. Robinson
Publication date
28-09-2024
Publisher
Springer US
Published in
Lung / Issue 6/2024
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-024-00749-4

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more